Bank Hapoalim BM’s AbbVie ABBV Stock Holding History

Bank Hapoalim BM’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.23M	Hold	17,417	–	–	0.44%	47
2025 Q1	$3.65M	Sell	17,417 -185	-1%	-$38.8K	0.53%	41
2024 Q4	$3.13M	Sell	17,602 -1,843	-9%	-$328K	0.51%	47
2024 Q3	$3.84M	Sell	19,445 -509	-3%	-$101K	0.58%	46
2024 Q2	$3.42M	Sell	19,954 -2,159	-10%	-$370K	0.48%	51
2024 Q1	$4.03M	Sell	22,113 -738	-3%	-$134K	0.52%	49
2023 Q4	$3.54M	Sell	22,851 -830	-4%	-$129K	0.48%	49
2023 Q3	$3.53M	Sell	23,681 -6,659	-22%	-$993K	0.57%	45
2023 Q2	$4.09M	Sell	30,340 -3,625	-11%	-$488K	0.58%	46
2023 Q1	$5.41M	Sell	33,965 -5,145	-13%	-$820K	0.75%	42
2022 Q4	$6.32M	Sell	39,110 -846	-2%	-$137K	0.79%	43
2022 Q3	$5.36M	Sell	39,956 -1,205	-3%	-$162K	0.67%	45
2022 Q2	$6.3M	Sell	41,161 -920	-2%	-$141K	0.78%	40
2022 Q1	$6.82M	Buy	42,081 +9,421	+29%	+$1.53M	0.71%	44
2021 Q4	$4.42M	Buy	32,660 +2,685	+9%	+$364K	0.44%	59
2021 Q3	$3.23M	Buy	29,975 +780	+3%	+$84.1K	0.34%	72
2021 Q2	$3.29M	Sell	29,195 -801	-3%	-$90.2K	0.37%	66
2021 Q1	$3.25M	Sell	29,996 -65	-0.2%	-$7.03K	0.41%	60
2020 Q4	$3.22M	Sell	30,061 -560	-2%	-$60K	0.45%	51
2020 Q3	$2.68K	Sell	30,621 -1,679	-5%	-$147	0.13%	43
2020 Q2	$3.17M	Sell	32,300 -165	-0.5%	-$16.2K	0.74%	34
2020 Q1	$2.47M	Buy	32,465 +4,830	+17%	+$368K	0.78%	31
2019 Q4	$2.45M	Buy	27,635 +485	+2%	+$42.9K	0.54%	37
2019 Q3	$2.03M	Buy	27,150 +8,610	+46%	+$644K	0.5%	38
2019 Q2	$1.35M	Buy	18,540 +3,110	+20%	+$226K	0.33%	55
2019 Q1	$1.24M	Buy	15,430 +1,865	+14%	+$150K	0.3%	60
2018 Q4	$1.25M	Buy	13,565 +1,630	+14%	+$150K	0.4%	56
2018 Q3	$1.13M	Buy	11,935 +5,095	+74%	+$482K	0.27%	70
2018 Q2	$634K	Buy	6,840 +1,340	+24%	+$124K	0.17%	105
2018 Q1	$521K	Sell	5,500 -465	-8%	-$44K	0.14%	113
2017 Q4	$577	Buy	5,965 +545	+10%	+$53	0.13%	122
2017 Q3	$482K	Sell	5,420 -250	-4%	-$22.2K	0.11%	141
2017 Q2	$411K	Buy	5,670 +1,150	+25%	+$83.4K	0.1%	144
2017 Q1	$295K	Buy	+4,520	New	+$295K	0.07%	159